Works matching IS 21534888 AND DT 2021 AND VI 12 AND IP 4
Results: 10
Truseltiq (Infigratinib) New Targeted Therapy FDA Approved for Advanced or Metastatic Cholangiocarcinoma Harboring FGFR2 Alterations.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 13
- By:
- Publication type:
- Article
Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 12
- By:
- Publication type:
- Article
Early Phase 3 Results Show Survival Benefit with Nivolumab-Based Regimens in Advanced Esophageal Squamous-Cell Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 11
- By:
- Publication type:
- Article
177Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 10
- By:
- Publication type:
- Article
Novel LAG-3-Blocking Antibody plus Nivolumab Shows Promise as First-Line Treatment in Advanced Melanoma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 9
- By:
- Publication type:
- Article
New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple...
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 8
- By:
- Publication type:
- Article
ASCO 2021 Presidential Address: Eliminating Disparities in Cancer...
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 7
- Publication type:
- Article
Rylaze FDA Approved as Part of a Treatment Regimen for Leukemia or Lymphoma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 6
- Publication type:
- Article
Rapid Biosimilar Adoption Possible in Community Oncology...
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 6
- Publication type:
- Article
Atezolizumab Extends Disease-Free Survival in Patients with PD-L1-Positive Early-Stage...
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 4, p. 5
- Publication type:
- Article